9999999997-19-002779.txt : 20190411 9999999997-19-002779.hdr.sgml : 20190411 20190411162905 ACCESSION NUMBER: 9999999997-19-002779 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190411 DATE AS OF CHANGE: 20190411 ACTION DATE: 20190411 RECEIVED DATE: 20190411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-36294 FILM NUMBER: 19744117 BUSINESS ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP BUSINESS PHONE: 1-339-970-7000 MAIL ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 CT ORDER 1 filename1.pdf begin 644 filename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

')E9@T*-C